Diallyl disulfide down‐regulates calreticulin and promotes C/EBPα expression in differentiation of human leukaemia cells
Authors:
Open Access
- 5 November 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 23 (1) , 194-204
Abstract
Diallyl disulfide (DADS), the main active component of the cancer fighting allyl sulfides found in garlic, has shown potential as a therapeutic agent in various cancers. Previous studies showed DADS induction of HL‐60 cell differentiation involves down‐regulation of calreticulin (CRT). Here, we investigated the mechanism of DADS‐induced differentiation of human leukaemia cells and the potential involvement of CRT and CCAAT enhancer binding protein‐α (C/EBPα). We explored the expression of CRT and C/EBPα in clinical samples (20 healthy people and 19 acute myeloid leukaemia patients) and found that CRT and C/EBPα expressions were inversely correlated. DADS induction of differentiation of HL‐60 cells resulted in down‐regulated CRT expression and elevated C/EBPα expression. In severe combined immunodeficiency mice injected with HL‐60 cells, DADS inhibited the growth of tumour tissue and decreased CRT levels and increased C/EBPα in vivo. We also found that DADS‐mediated down‐regulation of CRT and up‐regulation of C/EBPα involved enhancement of reactive oxidative species. RNA immunoprecipitation revealed that CRT bound C/EBPα mRNA, indicating its regulation of C/EBPα mRNA degradation by binding the UG‐rich element in the 3′ untranslated region of C/EBPα. In conclusion, the present study demonstrates the C/EBPα expression was correlated with CRT expression in vitro and in vivo and the molecular mechanism of DADS‐induced leukaemic cell differentiation.Keywords
Funding Information
- National Natural Scientific Foundation of China (81400117, 81602249)
- Returned Personnel Initial Funding of University of South China (2014XQD46)
- Hunan Provincial Natural Science Foundation of China (2015JJ4042, 2018JJ3454)
- Hunan Provincial Postgraduate Students Scientific Research Innovation Project (CX2016B473)
- The Science and Technology Development Project (2017KJ286)
This publication has 46 references indexed in Scilit:
- Molecular mechanisms for the anti-cancer effects of diallyl disulfideFood and Chemical Toxicology, 2013
- CCAAT/Enhancer-Binding Protein-α Suppresses Lung Tumor Development in Mice through the p38α MAP Kinase PathwayPLOS ONE, 2013
- Wogonin Induced Calreticulin/Annexin A1 Exposure Dictates the Immunogenicity of Cancer Cells in a PERK/AKT Dependent MannerPLOS ONE, 2012
- All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)Blood, 2012
- Acute myeloid leukemia stem cells and CD33-targeted immunotherapyBlood, 2012
- Involvement of Mcl1 in diallyl disulfide-induced G2/M cell cycle arrest in HL-60 cellsOncology Reports, 2012
- C/EBPα mediates the transcriptional suppression of human calreticulin gene expression by TNFαThe International Journal of Biochemistry & Cell Biology, 2012
- What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?Current Hematologic Malignancy Reports, 2011
- Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AMLBlood, 2011
- Role of Ras‐related C3 botulinum toxin substrate 2 (Rac2), NADPH oxidase and reactive oxygen species in diallyl disulphide‐induced apoptosis of human leukaemia HL‐60 cellsClinical and Experimental Pharmacology and Physiology, 2010